This is a study to determine the safety and effectiveness of different doses of Cymbalta (duloxetine) compared to a placebo in reducing pain in multiple sclerosis patients who have central neuropathic pain. This national study is currently recruiting adults who meet these criteria.
Read moreHi everybody! It is Thursday evening and I am sitting here feeling grateful. I went to the beach today with my family and nothing bad... Read more »
April, cruel path to no salvationleaving the March splitting in your wakeApril, thy name is sufferingamid the inflammationand the... Read more »
Have you ever had an extraordinary pain that doesn't respond to medication, one that has a team of doctors scratching their heads as they... Read more »
Meditation and yoga can be beneficial to those of us with MS. Meditation is a contemplative mental exercise for complete relaxation or... Read more »
Multiple sclerosis is not a painful disease, right? Wrong. The pain associated with MS can vary from an occasional annoyance to a... Read more »
Bayer has announced that it will begin marketing the thinnest needle available for injecting its disease-modifying drug Betaferon in people with... Read more »
This is a study to evaluate the safety and effectiveness of Cymbalta compared to a placebo in treating pain in people who have multiple sclerosis... Read more »
A new study has found that the experimental drug Sativex may offer long-term relief from neuropathic pain for patients with multiple sclerosis (MS).... Read more »
Source: Harvard Decision Guide
What Is It? Multiple sclerosis, sometimes called just MS, is a disabling, neurological illness that affects the brain and spinal cord. The disease... Read more »